Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Total Liabilities (2022 - 2025)

CervoMed's Total Liabilities history spans 9 years, with the latest figure at $4.6 million for Q3 2025.

  • For Q3 2025, Total Liabilities rose 41.68% year-over-year to $4.6 million; the TTM value through Sep 2025 reached $4.6 million, up 41.68%, while the annual FY2024 figure was $3.9 million, 49.45% up from the prior year.
  • Total Liabilities for Q3 2025 was $4.6 million at CervoMed, down from $4.6 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $60.2 million in Q2 2022 and bottomed at $2.1 million in Q1 2023.
  • The 4-year median for Total Liabilities is $3.9 million (2024), against an average of $12.1 million.
  • The largest annual shift saw Total Liabilities plummeted 95.76% in 2023 before it skyrocketed 49.45% in 2024.
  • A 4-year view of Total Liabilities shows it stood at $13.2 million in 2022, then plummeted by 80.27% to $2.6 million in 2023, then surged by 49.45% to $3.9 million in 2024, then rose by 18.56% to $4.6 million in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Total Liabilities are $4.6 million (Q3 2025), $4.6 million (Q2 2025), and $3.9 million (Q1 2025).